A Study to Assess the Effect AZD4831 in Japanese and Chinese Healthy Volunteers

NCT04232345 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction (HFpEF)

Interventions

DRUG: AZD4831
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]